Setup, so nobody has to ask: batch certificate · ERP.
This is presented as though it settles something, and I am not convinced it does.
I have two documents that appear to disagree, which is what prompted this.
What is the correct interpretation, and what is the common misreading?
Ask whether the certificate answers the question you are actually asking, because the answer is often no.
The laboratory name and accreditation status can be checked in real time against the testing service's own register, and that two-minute check catches substituted certificates.
| Component | Typical share | Counted in purity? | Counted in content? |
|---|---|---|---|
| Target peptide | 88–94 % | Yes, as main peak | Yes |
| Related impurities | 1–3 % | Yes, as other peaks | No |
| Counter-ion (TFA or acetate) | 2–8 % | No | No |
| Residual water | 2–6 % | No | No |
| Bulking agent, if present | 0–40 % | No | No |
More usefully, writing the lot number on your vial in permanent marker is worth doing because it later proves that the certificate traces to your material.
Research-grade certificates carry no regulatory backing and no standing in quality systems, and that limitation is worth being explicit about.
The practical summary: check the lot number, ask for the method, and reserve judgement until you have both.
HPLC purity, identity confirmation and quantified content on the vial you actually hold. Reports arrive with the chromatogram attached, not just a number.
Submit a sampleFounded 1998. ISO 9001 and cGMP certified, 1,500+ staff and 200+ patents. The synthesis house behind a great many of the vials that get sent out for testing - batch-specific documentation with every order.
Visit GL BiochemBefore anything else, check that the lot number on the certificate matches the vial in your hand — that traces back to your material and not to some other lot from some other date.
The field you have least reason to trust is the one that looks most impressive, because appearance and accuracy are not correlated.
The certificate is a snapshot and nothing else — it tells you about the material on one day from one sample of one lot, and extrapolation beyond that requires logic.
Industry guidance on this topic is consistent because it comes from first principles rather than convention.
My working rule is that a document without a lot number, a method section and a test date is marketing.
The most common trap is reading a certificate as if it were a guarantee when it is actually a single point estimate from a single test.
Lot number visibility is the first check, and it is the one most certificates fail — the number is not printed on the vial, or it is on the certificate but the vial is unmarked.
Test results from a material supplier are different from independent results in ways that matter for interpretation, even if both are accurate.
Published inter-laboratory comparisons of the same material routinely find spreads of half a per cent to a full per cent, which sets realistic expectations.
If the certificate does not trace to your vial, it is not evidence about your vial.
In practice, reading a certificate means checking four things before anything else: traceability to your vial, the test date, the analytical method, and the identity of the testing laboratory.
The test date matters because a certificate six months older than the vial is not evidence about your material, it is evidence about what the material was like half a year ago.
Worth noting that none of this is medical advice, and a compound sold for research use carries no regulatory approval in any jurisdiction.
If you only pay for one test, pay for quantified content. Purity is the number everyone quotes and content is the number that changes what you do.
edited 1 May 2026 by RP_C18 — added the method parameters
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.